stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. ONCO
    stockgist
    HomeTop MoversCompaniesConcepts
    ONCO logo

    Onconetix, Inc.

    ONCO
    NASDAQ
    Healthcare
    Biotechnology
    Cincinnati, OH, US12 employeesonconetix.gcs-web.com
    $1.48
    -0.40(-21.08%)

    Mkt Cap $5M

    $1.49
    $39.45

    52-Week Range

    At a Glance

    AI-generated

    Onconetix, Inc.

    Revenue breakdown: Development Service (68.2%), Other Revenues (17.6%), Product Sales (14.2%).

    8-K/A
    Onconetix, Inc. appointed David White as Chief Executive Officer effective March 18, 2026, with a monthly base salary of $21,700 under a new employment agreement. The Board accepted Timothy Ramdeen's resignation effective March 19, 2026, appointed Sammy Dorf as a director and Audit Committee member, and reduced compensation for Karina Fedasz by $5,000 monthly and Andrew Oakley by $26,000.

    $5M

    Market Cap

    $496.3K

    Revenue

    -$9M

    Net Income

    Employees12
    Fundamentals

    How The Business Makes Money

    Revenue by Segment

    Development Service68.2%($5M)
    Other Revenues17.6%($1M)
    Product Sales14.2%($949.7K)
    License0%($1)

    Revenue by Geography

    European Union65%($6M)
    CH32.5%($3M)
    US1.3%($126.2K)
    Non European Union0.9%($85.2K)
    GB0.4%($42.6K)
    Activity

    What Changed Recently

    Management Change
    Mar 24, 2026

    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Appointment of

    Material Agreement
    Feb 11, 2026

    Entry into a Material Definitive Agreement. This section describes the material provisions of the Share Exchange Agreement (as defined below) but does not purpo

    Shareholder Vote
    Feb 8, 2026

    Submission of Matters to a Vote of Security Holders. On February 3, 2026, Onconetic, Inc. (the “ Compan y”) held a special meeting of stockholders (the “ Specia

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    JSPRJasper Therapeutics, Inc.$0.72-9.38%$12M-0.2
    SLRXSLRX$0.84+29.23%$5M—
    INDPIndaptus Therapeutics, In...$1.57-7.35%$3M-0.2
    AZTRAzitra, Inc.$0.23-4.21%$2M—
    REVBRevelation Biosciences, I...$1.22-0.80%$2M-0.8
    ENVBEnveric Biosciences, Inc.$2.03-5.14%$1M-0.1
    PTIXProtagenic Therapeutics, ...$0.53+1.92%$1M-0.3
    SCNIScinai Immunotherapeutics...$0.60-6.12%$789.2K-0.1
    Analyst View
    Company Profile
    CIK0001782107
    ISINUS68237Q2030
    CUSIP68237Q203
    Phone513 620 4101
    Address201 East Fifth Street, Cincinnati, OH, 45202, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice